News

News
JNJ Press releases

Big Pharma’s Billion-Dollar Scramble to Invest in Start-ups to Fuel Innovation

Read full story
JNJ Press releases

Helsinn Group announces agreement to acquire worldwide rights to Valchlor®/Ledaga® - an approved and marketed alkylating agent for the topical treatment of mycosis fungoides‐type cutaneous T‐cell lymphoma, a rare type of skin cancer

Read full story
JNJ Press releases

Johnson & Johnson Innovation Launches Advancing the Safe Use of Healthcare Products QuickFire Challenge

Read full story
JNJ Press releases

Johnson & Johnson Innovation launches Singapore QuickFire Challenge Competition in collaboration with ETPL and SMART to accelerate solutions for diabetes and other metabolic diseases

Read full story
JNJ Press releases

Johnson & Johnson Innovation Launches a New Company Incubation Model Located at the Janssen Research & Development Campus in Beerse, Belgium

Read full story
JNJ Press releases

Bioqube ventures launches specialist investment firm and announces collaboration with Johnson & Johnson Innovation, JLINX

Read full story
JNJ Press releases

Johnson & Johnson Innovation Launches JLINX: A New Company Incubation Model Located at the Janssen Campus in Belgium

Read full story
JNJ Press releases

Johnson & Johnson Innovation Launches JLINX: A New Company Incubation Model Located at the Janssen Campus in Belgium

Read full story
JNJ Press releases

Johnson & Johnson Innovation Unveils JLABS @ TMC to Help Catalyze Early Stage Research through to Commercialization for Healthcare Solutions in Houston

Read full story
JNJ Press releases

LifeScan Announces Strategic Collaboration with WellDoc Corporation to Advance Mobile Care Solutions for Type 2 Diabetes Patients

Read full story
JNJ Press releases

Janssen Acquires XO1 Limited

Read full story
JNJ Press releases

Johnson & Johnson Announces Opening of London Innovation Centre

Read full story